Other well described factors involved in the process are: hyperphosphatemia, high parathyroid hormone (PTH) serum levels, vitamin D deficiency, elevated fibroblast growth factor 23 (FGF23) plasma levels, in addition to the presence of adenosylhomocysteine, hypervolemia, and anemia, among others. This evidence concerns the gene PTH and anemia (phenotype).